Literature DB >> 21438782

Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells.

Kazunori Kageyama1, Yukiko Kumata, Kanako Akimoto, Shinobu Takayasu, Naoki Tamasawa, Toshihiro Suda.   

Abstract

Corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) play a central role in regulating the stress response. In response to stress, CRF and AVP neurons in the hypothalamic paraventricular nucleus secrete the peptides to stimulate the release of adrenocorticotropic hormone from the anterior pituitary. Ghrelin, an endogenous ligand of the growth hormone-releasing peptide receptors (GHSR), has been shown to stimulate the release of CRF and AVP by rat hypothalamic explants. However, little is known about the ability of the ghrelin signaling pathways to activate the CRF and AVP genes in the hypothalamus. In the present study, we examined the direct effect of ghrelin on CRF and AVP gene expression in hypothalamic 4B cells, which show the characteristics of the hypothalamic parvocellular paraventricular nucleus neurons. Cells were transfected with CRF or AVP promoter to examine the activity of each promoter. Ghrelin stimulated the promoter activities and mRNA levels for both CRF and AVP. The involvement of a protein kinase pathway was examined using inhibitors. Protein kinase A and phospholipase C pathways were shown to be involved in ghrelin-induced increases in both CRF and AVP promoter activities. GHSR type 1a (GHSR1a) mRNA levels were also increased by ghrelin, and these ghrelin-induced levels were suppressed by a GHSR1a antagonist. Thus, ghrelin-dependent pathways are involved in the regulation of CRF and AVP gene expression in the hypothalamus: ghrelin, an orexigenic hormone, stimulates CRF, an anorexigenic/anxiogenic factor in the hypothalamus, resulting in hypothalamic-pituitary-adrenal axis activation to stimulate the release of glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21438782     DOI: 10.3109/10253890.2011.558605

Source DB:  PubMed          Journal:  Stress        ISSN: 1025-3890            Impact factor:   3.493


  14 in total

1.  CRF type 2 receptors mediate the metabolic effects of ghrelin in C2C12 cells.

Authors:  Eran Gershon; Wylie W Vale
Journal:  Obesity (Silver Spring)       Date:  2013-09-10       Impact factor: 5.002

Review 2.  Mood disorders: A potential link between ghrelin and leptin on human body?

Authors:  Stalo Zarouna; Greta Wozniak; Anastasia Ioannis Papachristou
Journal:  World J Exp Med       Date:  2015-05-20

Review 3.  Stress-related alterations of acyl and desacyl ghrelin circulating levels: mechanisms and functional implications.

Authors:  Andreas Stengel; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2011-07-12       Impact factor: 3.750

4.  Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study.

Authors:  Carolina L Haass-Koffler; Victoria M Long; Mehdi Farokhnia; Molly Magill; George A Kenna; Robert M Swift; Lorenzo Leggio
Journal:  Neuropharmacology       Date:  2019-07-13       Impact factor: 5.250

5.  Ghrelin-Induced Enhancement of Vasopressin and Oxytocin Secretion in Rat Neurohypophyseal Cell Cultures.

Authors:  M Gálfi; M Radács; Zs Molnár; I Budai; G Tóth; A Pósa; K Kupai; Z Szalai; R Szabó; H A Molnár; J Gardi; Ferenc A László; Cs Varga
Journal:  J Mol Neurosci       Date:  2016-10-17       Impact factor: 3.444

6.  Ghrelin - a pleiotropic hormone secreted from endocrine x/a-like cells of the stomach.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Neurosci       Date:  2012-02-16       Impact factor: 4.677

7.  Serum ghrelin and leptin levels in patients with depression and the effects of treatment.

Authors:  Saliha Ozsoy; Aslı Besirli; Ummuhan Abdulrezzak; Mustafa Basturk
Journal:  Psychiatry Investig       Date:  2014-04-11       Impact factor: 2.505

Review 8.  Gut-Brain Neuroendocrine Signaling Under Conditions of Stress-Focus on Food Intake-Regulatory Mediators.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

9.  Epigenetic Control of the Vasopressin Promoter Explains Physiological Ability to Regulate Vasopressin Transcription in Dehydration and Salt Loading States in the Rat.

Authors:  M P Greenwood; M Greenwood; B T Gillard; S Y Loh; J F R Paton; D Murphy
Journal:  J Neuroendocrinol       Date:  2016-04       Impact factor: 3.627

Review 10.  Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders.

Authors:  Ewa Szczepanska-Sadowska; Katarzyna Czarzasta; Agnieszka Cudnoch-Jedrzejewska
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.